Viktor Siewertz joins PulPac from IRLAB Therapeutics AB, listed on Nasdaq Stockholm Main Market, where he has served as CFO since 2017. With over 25 years of experience in finance, law, and corporate governance, he brings extensive expertise in accounting, capital markets, financial strategy, and investor relations. During his tenure at IRLAB, Siewertz played a pivotal role in leading its financial strategy from the company’s formation through a listing on Nasdaq Stockholm Main Market. His professional background also includes leadership positions in M&A, financial advisory, and business development across different industries.
“We are very pleased to welcome Viktor to PulPac. His deep knowledge of capital markets, corporate governance, and financing will strengthen our leadership team as we continue to scale Dry Molded Fiber globally,” said Linus Larsson Green, CEO of PulPac. “We are also pleased that Roderick Sundell will continue to support PulPac in a new role focusing on Corporate Development and want to thank him for his dedication in taking us from a start-up to the promising scale-up we are today.”
“PulPac is a company with a clear mission and strong potential. I am excited to join the team and contribute to advancing the financial strategy and long-term value creation,” said Viktor Siewertz.
The transition strengthens PulPac’s leadership team, with Viktor Siewertz focusing on financial governance, operations and long-term value creation, while Roderick Sundell takes on a strategic role in Corporate Development, driving growth initiatives, forging new partnerships, and deepening engagement with PulPac’s investor and stakeholder community.
Learn more at www.pulpac.com